Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Lipopolysaccharide Is a Direct Agonist for Platelet RNA Splicing
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
2005
Ischemia‐reperfusion selectively impairs nitric oxide‐ mediated dilation in coronary arterioles: counteracting role of arginase
2003
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
Aprotinin Versus Lysine Analogues: The Debate Continues
1998
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
2005
Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients
2004
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)*
2005
Operation for Infective Endocarditis: Results After Implantation of Mechanical Valves
1998
Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
2008
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
2003
Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience
2007
Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy
2005
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens
1996
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease
2003
Postoperative pulmonary embolism detected with multislice computed tomography in lung surgery for cancer
2006
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents
2008
Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass
2005
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
2008
Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy
2007
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial
2009
Pharmacology of Antiplatelet Agents
2013
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*
2006
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
2012
Indirect comparison meta-analysis of aspirin therapy after coronary surgery
2003
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Bladder cancer
2016 Standout
Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions
2004
Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience
2007
The Risk Associated with Aprotinin in Cardiac Surgery
2006
Platelets and the immune continuum
2011 Standout
Prevention of Venous Thromboembolism
2004 Standout
Thromboembolism after pneumonectomy for malignancy: An independent marker of poor outcome
2006
Sickle-cell disease
2010 Standout
Ascending Thoracic Aneurysms Are Associated With Decreased Systemic Atherosclerosis
2005
Aspirin and Antiplatelet Agent Resistance
2010
The case for surgery in obstructive hypertrophic cardiomyopathy
2004
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
1998
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Prevention of Venous Thromboembolism
2008 Standout
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-The baylor experience (1996-2002)
2005
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
2005
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Aprotinin Shows Both Hemostatic and Antithrombotic Effects During Off-Pump Coronary Artery Bypass Grafting
2005
Homograft replacement of the mitral valve
1996
Infective endocarditis
2004 Standout
Update on Tumor Cell Procoagulant Factors
2001
Prevention and Treatment of Major Blood Loss
2007
Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations
1998
Familial Thoracic Aortic Aneurysms and Dissections—Incidence, Modes of Inheritance, and Phenotypic Patterns
2006
Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
2002
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction
2013
Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
2007
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
2013
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
2010
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Interventions for protecting renal function in the perioperative period
2013
Aspirin and Antiplatelet Agent Resistance
2010
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery11Supported, in part, by grant NCC9-60 from the National Aeronautics and Space Administration, Houston, Texas, Grant #9951522V from the America Heart Association Ohio Local Chapter, Columbus, Ohio and Grant #R01 HL56688-01A1 from the National Institutes of Health, Bethesda, Maryland.22Presented, in part, at the 49th Annual Scientific Sessions of American College of Cardiology, March 2000, Anaheim, California.
2001
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions
2002
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy
2012
Effects of Levosimendan on Left Ventricular Relaxation and Early Filling at Maintained Preload and Afterload Conditions After Aortic Valve Replacement for Aortic Stenosis
2008
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy
2005
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of E. Gams being referenced
Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study
2006
Management of Symptomatic Hypertrophic Obstructive Cardiomyopathy - Long-Term Results after Surgical Therapy
1999
Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin
2001
Hypertrophische Kardiomyopathie (HCM) Chirurgische versus medikamentöse Therapie
1999
Pulmonary embolism: a frequent cause of acute fatality after lung resection
1996
Aspirin-induced platelet inhibition in patients undergoing cardiac surgery
2007
Gene Expression Profiles in the Acutely Dissected Human Aorta
2002
Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting
1995
Flow cytometry analysis of platelet cyclooxygenase‐2 expression: induction of platelet cyclooxygenase‐2 in patients undergoing coronary artery bypass grafting
2002
Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?1
1998
Efficiency of a computer network in the administrative and medical field of cardiac surgery Concept of and experience with a departmental system
1990
Aspirin resistance after coronary artery bypass grafting
2001
Predictors of Homologous Blood Transfusion for Patients Undergoing Open Heart Surgery
2003
Markers of Activated Hemostasis and Fibrinolysis in Patients with Pulmonary Malignancies
2000
Importance of the left ventricular subvalvular apparatus for cardiac performance.
1993
Impact of mitral valve repair in patients with mitral regurgitation undergoing coronary artery bypass grafting
2009
Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
2003
Aortic valve replacement in octogenarians: outcome and predictors of complications.
2011
Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction.
2006